Latest1 information on COVID-19
©2022 Stanford Medicine
Trial ID: NCT00363662
Diagnostic Utility of MRI in Intracerebral Hemorrhage
Clinical Professor, Neurology & Neurological Sciences
Clinical Professor, Neurology & Neurological Sciences Clinical Professor (By courtesy), Neurosurgery
Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery
A. Men and non-pregnant women, at least 18 years of age.
B. Patients with an ICH or IVH admitted to Stanford University Medical center within 48
hours of symptom onset.
C. Ability to undergo MRI.
A. Patients with a known (preexisting) source for ICH, for example a known untreated
B. Patients receiving investigational drug therapies or procedures prior to MRI scanning.
C. Glasgow coma scale (GCS) score < 6 in the absence of sedating medications.
D. Informed consent cannot be obtained either directly from the patient or from a legally
E. Severe coexisting or terminal systemic disease that limits life expectancy or that may
interfere with the conduct of the study
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Stephanie M Kemp, BS